Question of the Day May 27, 2016 How many other compounders and/or doctors are repackaging medications "for no purpose other than increasing their profits," as is alleged in the Melgen litigation in Florida

The lawsuits allege the bacterial contamination stemmed from Melgen's profit-driven decision to repackage single-use vials of ocular drugs, primarily the macular degeneration drug Lucentis.      According to the complaints, Melgen ordered the repackaging of Lucentis vials into multiple doses, in disregard for manufacturer guidelines, and in defiance of the Centers for Disease Control's warnings to the medical community that compounding the drug could cause it to become tainted with bacteria prior to injection.      Melgen and his medical group, Vitreo-Retinal Consultants, carried out the Lucentis repackaging "for no purpose other than increasing their profits," according to Richard Doyle, a Fort Lauderdale attorney who represents the majority of the plaintiffs.

quoted from http://www.courthousenews.com/2016/05/27/legal-woes-mount-for-menendez-scandal-doc.htm